KUALA LUMPUR, Nov 9 (Bernama) — AmMetLife Insurance Berhad (“AmMetLife”) and Pantai Premier Pathology Sdn. Bhd. (“Pantai Premier Pathology”) have signed a Memorandum of Understanding (MOU) extending their existing collaboration for two more years. Through this collaboration, AmMetLife’s medical plan customers will be able to access preferential rates when undergoing genomic testing for cancer at Pantai Premier Pathology’s network of 14 medical facilities across Malaysia.
The MOU covers 47 different tests, including BRCA for breast and ovarian cancer as well as EGFR for lung cancer, which can help to assist physicians in making more informed treatment decisions for cancer patients.
